Valsartan. Just a second-line antihypertensive drug
- PMID: 10587770
- PMCID: PMC2328654
Valsartan. Just a second-line antihypertensive drug
Abstract
Valsartan (Diovan) is an antihypertensive drug belonging to the family of angiotensin II receptor antagonists. At a dose of 40 mg/d, its antihypertensive effect is inconsistent. At 80 mg/d its effect on blood pressure, its adverse effects, and its contraindications (mainly pregnancy and renal artery stenosis) are similar to those of angiotensin-converting enzyme (ACE) inhibitors, except that coughing is rarer with valsartan than with ACE inhibitors. Valsartan has no demonstrated advantage over losartan, another angiotensin II antagonist. Valsartan has not been shown to prevent complications of arterial hypertension, and its use is, therefore, less well validated than that of diuretics and beta-blockers.
Similar articles
-
Valsartan: new preparation. Just a second-line antihypertensive drug.Prescrire Int. 1998 Oct;7(37):144-5. Prescrire Int. 1998. PMID: 10915419
-
Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.Prescrire Int. 2005 Oct;14(79):180-6. Prescrire Int. 2005. PMID: 16285075
-
Angiotensin receptor blockers and myocardial infarction: the importance of dosage.J Hypertens. 2006 Aug;24(8):1679-81; author reply 1681-2. doi: 10.1097/01.hjh.0000239307.86248.80. J Hypertens. 2006. PMID: 16877973 No abstract available.
-
Fixed combination therapy of hypertension: focus on valsartan/hydrochlorothiazide combination (Diovan/HCT).Expert Rev Cardiovasc Ther. 2003 Sep;1(3):335-43. doi: 10.1586/14779072.1.3.335. Expert Rev Cardiovasc Ther. 2003. PMID: 15030262 Review.
-
Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.Adv Ther. 2008 Apr;25(4):300-20. doi: 10.1007/s12325-008-0042-x. Adv Ther. 2008. PMID: 18449492 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous